Biohaven Ltd (BHVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 99,134 | 248,402 | 240,089 | 76,057 | 132,149 |
| Marketable Securities | 386,857 | 133,417 | 260,464 | 0 | 223,185 |
| Receivables | 2,597 | 13,252 | 46,139 | 9,911 | 120,111 |
| Inventories | N/A | N/A | N/A | N/A | 39,563 |
| Other current assets | 508 | 12,133 | 19,331 | 2,121 | 11,716 |
| TOTAL | $538,472 | $442,446 | $586,968 | $94,823 | $603,406 |
| Non-Current Assets | |||||
| PPE Net | 17,320 | 17,191 | 17,512 | 13,010 | 9,340 |
| Investments And Advances | 0 | 0 | 0 | 0 | 1,176 |
| Intangibles | 19,790 | 19,790 | 19,790 | 19,790 | 39,087 |
| Other Non-Current Assets | 39,525 | 33,785 | 37,513 | 14,438 | 33,966 |
| TOTAL | $76,635 | $70,766 | $74,815 | $47,238 | $83,569 |
| Total Assets | $615,107 | $513,212 | $661,783 | $142,061 | $686,975 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,029 | 15,577 | 10,703 | 4,775 | 48,476 |
| Accrued Expenses | 51,487 | 39,846 | 44,106 | 37,160 | 166,630 |
| Other current liabilities | 84,710 | 0 | 35,212 | N/A | 62,500 |
| TOTAL | $154,226 | $55,423 | $90,021 | $41,935 | $277,606 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 267,458 |
| Other Non-Current Liabilities | 37,445 | 29,814 | 32,991 | 65,435 | 534,100 |
| TOTAL | $37,445 | $29,814 | $32,991 | $65,435 | $801,558 |
| Total Liabilities | $191,671 | $85,237 | $123,012 | $107,370 | $1,079,164 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 102,055 | 81,580 | 68,212 | 70,524 | 61,915 |
| Common Shares | 1,656,702 | 887,528 | 615,742 | N/A | 1,249,547 |
| Retained earnings | -1,345,714 | -499,292 | -91,124 | 0 | -1,739,169 |
| Other shareholders' equity | 79 | -65 | 284 | 34,691 | -1,505 |
| TOTAL | $423,436 | $427,975 | $538,771 | $34,691 | $-392,189 |
| Total Liabilities And Equity | $615,107 | $513,212 | $661,783 | $142,061 | $686,975 |